Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

N-(mercaptoacetyl)glycine

Known as: N-MAG-3, mercaptoacetyl-Gly, mercaptoacetylglycine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
BACKGROUND Ureteral tapering and reimplantation is an established treatment for persistent or progressive primary obstructive… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
2011
2011
The 7-(2-aminoethylamino)-5-methyl-3-cyanopyrazolo[1,5-a]pyrimidine (AMCPP) was synthesized and conjugated with N… Expand
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 3
Is this relevant?
2008
2008
The effects of polar (mercaptoacetyl-triseryl) and negatively charged (mercaptoacetyl-triglumatyl) chelators on the… Expand
Is this relevant?
2006
2006
A 48-year-old man presented with malignant hypertension and massive proteinuria. Renal angiography showed complete obstruction of… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2006
2006
A 61-year-old male developed end-stage renal failure in January 1994, with a presumptive diagnosis of hypertensive… Expand
  • figure 1
Is this relevant?
2005
2005
BackgroundScintigraphic image analysis of99mTc-mertiatide (Mag-3, mercaptoacetyltriglycine) clearance provides the determination… Expand
  • figure 1
Is this relevant?
2004
2004
3042 Background: CYC202 is an oral cyclin dependent kinase inhibitor of CDKs-2, -7 and -9, leading to inhibition of… Expand
Is this relevant?
2001
2001
Abstract. Technetium-99m mercaptoacetylglycine (99mTc-MAG3) renography is a successful non-invasive method for the evaluation of… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
2000
2000
Bilateral acute cortical necrosis is a rare form of acute renal failure characterized by necrosis of the renal cortex and sparing… Expand
Is this relevant?
1989
1989
99mTechnetium mercaptoacetylglycine is a promising new renal radiopharmaceutical undergoing phase III trials in the United States… Expand
Is this relevant?